GZMO Message Board - Msg: 12233989

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GZMO

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (179)	12/9/1999 9:57:00 AM
From: biowa	Read Replies (3) of 438

Rick, <<Wording would imply "public gene". I would make the same assumption that you made, however.>> So what would their patent position be on a transcript identified by expression analysis? How about on the underlying gene? Sorry, I'm hazier on protein patent law than gene... <<If there's justice.>> Alas, the market likes it, but it doesn't seem to be BLASTING OFF. Dear Mr. Market: This is really great data that will lead to products (both therapeutic and diagnostic) much faster than silly old genomics. It's further down the pathway and relates the genes to actual disease states. It also suggests interrelations (sorry Mr. Market, I'll try to use simpler words) between the various transcripts that can't be derived from simple sequence. It also is a nice validation of the SAGE technology. Over here! Over here! Get your GZMO over here (but not from me) <g> biowa Mr. Market is a registered trademark of DAK

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next